SEC Form 4 · accession 0000784199-18-000038
ARTIVION, INC. · AORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B Capps
Officer — VP, Clinical Research
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000784199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2018 | A | 4,000 | $0.00 | A | 135,827 | D | |
| Common StockF2 | Mar 5, 2018 | F | 607 | $19.15 | D | 135,220 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date.
- F2These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.